Navigation Links
DeSilva + Phillips, Mediabankers, names Jim Brennan to Head Healthcare IT M&A Practice
Date:9/1/2009

DeSilva + Phillips, Media Investment Bankers, has announced that James R. Brennan, FACHE, will lead its Healthcare IT M&A practice. Formerly CEO of IncumediX and COO/CSO at MediServe Information Systems, Jim currently runs a business called VirtualCDO which has advised on over 140 transactions, including acquisitions, technology license and partnership deals, notably the sale of VanSlyck to Eclipsys Corporation (NASDAQ:ECLP), the sale of VasTech to Lawson Software (NASDAQ:LWSN) and the IPO of Craneware (LSE:CRW.L). As a managing director at DeSilva + Phillips, Jim can be reached at james@mediabankers.com.

New York (PRWEB) September 1, 2009 -- http:/www.mediabankers.com[DeSilva + Phillips, Mediabankers(tm), has appointed James R. Brennan, FACHE, as managing director. Jim will lead the DeSilva + Phillips Healthcare IT M&A practice, complementing the Life Sciences/Healthcare Media practice led by Moe Levitt, which has long been the leading provider of investment banking advisory services to the life sciences/healthcare media sector.

As CEO of VirtualCDO, a firm that provides technology and healthcare companies with outsourced corporate development officer services, Jim Brennan has completed over 140 transactions, including acquisition, technology license and partnership deals, notably the sale of VanSlyck to Eclipsys Corporation (NASDAQ:ECLP), the sale of VasTech to Lawson Software (NASDAQ:LWSN) and the IPO of Craneware (LSE:CRW.L). He is frequently quoted and is an frequent author on healthcare IT issues in media such as Group Practice Journal, Health Data Management, Health IT Strategist, Inside Healthcare Computing, MD&DI, MX and many others.

A Fellow of the American College of Healthcare Executives, Jim has had a distinguished career as a healthcare IT c-level and senior executive, including assignments as CEO of IncumediX, COO/CSO of MediServe Information Systems, Dir
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Microbia Names John McCarthy to Senior Management Team
2. NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
3. Biomodels Expands Efforts in Cancer Supportive Care, Pulmonary Fibrosis; Preclinical Research Organization Names Dr. Stephen T. Sonis as Partner
4. IDEV Technologies Names Veteran Medical Device Executive Rick Anderson Chairman of the Board of Directors
5. Kendle Names Jarrod Pontius Chief Legal Officer
6. Horizon Therapeutics Names Dr. Jeffrey W. Sherman Executive Vice President and Chief Medical Officer
7. Cequent Names F. Stephen Laroux, Ph.D., Director, Immunology and Inflammatory Diseases
8. Lexicon Names Ajay Bansal Executive Vice President and Chief Financial Officer
9. AIAA names top ten emerging aerospace technologies of 2009
10. Microbia, Inc. Names Alex Chu as Vice President of Process Development
11. Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... ... successful completion of a field clinical study of its canine osteoarthritis stem cell ... with Aratana Therapeutics (Kansas City, KS) and will be marketed in the US ...
(Date:7/30/2015)... LOUIS, July 30, 2015 HIGHLIGHTS:Q2 ... in 2014) , Reported sales were $697 million ... 2014.  Sales grew organically by 8%, and changes in ... acquisitions increased sales by 1%. , By business ... in Applied and 11% in SAFC Commercial. , ...
(Date:7/29/2015)... , July 30, 2015 ... la santé, publie ses résultats pour le premier ... commente les résultats. Visionner l,interview ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Au sommaire de ... - Moteurs de croissance - ...
(Date:7/29/2015)...  HealthSouth Corporation (NYSE: HLS ), ... healthcare services, offering both facility-based and home-based post-acute ... the second quarter ended June 30, 2015. ... volume growth in both segments and an 11.0% ... President and Chief Executive Officer of HealthSouth. "While ...
Breaking Biology Technology:VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 2VetStem Biopharma Successfully Completes Large Milestone Efficacy Study for its Flagship Canine Osteoarthritis Stem Cell Product 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20HealthSouth Reports Results for Second Quarter 2015 2HealthSouth Reports Results for Second Quarter 2015 3HealthSouth Reports Results for Second Quarter 2015 4HealthSouth Reports Results for Second Quarter 2015 5HealthSouth Reports Results for Second Quarter 2015 6HealthSouth Reports Results for Second Quarter 2015 7HealthSouth Reports Results for Second Quarter 2015 8HealthSouth Reports Results for Second Quarter 2015 9HealthSouth Reports Results for Second Quarter 2015 10HealthSouth Reports Results for Second Quarter 2015 11HealthSouth Reports Results for Second Quarter 2015 12HealthSouth Reports Results for Second Quarter 2015 13HealthSouth Reports Results for Second Quarter 2015 14HealthSouth Reports Results for Second Quarter 2015 15
... Co. LP has partnered,with BlueStar Capital Management LP to ... partnership also gives Carl Marks a stake in BlueStar,Capital ... presence in the healthcare investment sector., The new ... and short public healthcare equities, in both managed accounts ...
... 28 Kiadis Pharma announced today,the presentation of the ... by Dr. Stephan Mielke* and Dr. John Barrett* of ... of the National,Institutes of Health (NIH) on Kiadis, lead ... in Anaheim, California., According to the NHLBI investigators ...
... News briefs concerning the,economic and business growth in ... SRI Launches First Major Project to Improve Port Security, ... million contract,to develop a Maritime Domain Awareness (MDA) System ... port security in,the United States. The contract was awarded ...
Cached Biology Technology:Carl Marks Seeds New Healthcare Fund Through Strategic Partnership With BlueStar Capital Management 2Promising Data ATIR Studies Presented by NIH Investigators 2Highlights of Economic and Business Growth in the Tampa Bay Region 2Highlights of Economic and Business Growth in the Tampa Bay Region 3Highlights of Economic and Business Growth in the Tampa Bay Region 4
(Date:7/7/2015)... 7, 2015  Based on its recent analysis ... recognizes Credence ID, LLC with the 2015 Asia-Pacific ... the Year Award. Credence ID has developed a ... mission of offering enrollment and identification solutions to ... ID was formed by experts from the mobile ...
(Date:7/2/2015)... June 25, 2015 Research ... the "Next Generation Biometrics Market by Application, Technology, ... report to their offering. The next generation ... 2020, at a CAGR of 17.9% between 2015 and ... application for the market. Safran SA ( ...
(Date:6/30/2015)... , June 30, 2015 Genisphere ... company as CEO to help further develop Genisphere,s therapeutics ... of partnering experience, having spent much of the last ... Therakine, Amgen, Baxter Bioscience, and Johnson & Johnson. Tom ... on Technology and Biotech Corporate Finance. He graduated from ...
Breaking Biology News(10 mins):Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 2Next Generation Biometrics Market 2015 - Global Forecast to 2020 with Safran, NEC, 3M Cogent, Fujitsu & Suprema Dominating the $24 Billion Market 3Genisphere Appoints New CEO, Thomas Bliss 2Genisphere Appoints New CEO, Thomas Bliss 3
... bushes and other greenery growing in the concrete-and-glass canyons of ... air pollutants by eight times more than previously believed, a ... in the ACS journal Environmental Science & Technology. ... dioxide (NO 2 ) and microscopic particulate matter (PM) ...
... of California, Riverside believe they can extend the range ... taking into account real-time traffic information, road type and ... who work at the Center for Environmental Research and ... of Engineering, have received a nearly $95,000 one-year grant ...
... Model S to the Nissan Leaf, run on rechargeable lithium-ion ... half of the vehicle,s total cost. One promising alternative ... more energy at a much lower cost. But lithium-sulfur ... of charging and discharging, the battery stops working. ...
Cached Biology News:Extending the range of electric vehicles 2Extending the range of electric vehicles 3Stanford-SLAC team uses X-ray imaging to observe running batteries in action 2Stanford-SLAC team uses X-ray imaging to observe running batteries in action 3Stanford-SLAC team uses X-ray imaging to observe running batteries in action 4
... an aqueous solution that contains a purified ... in a MOPS buffer (3-(N-Morpholino) propanesulfonic acid), ... contains a combination of 0.02% methylisothiazolone, 0.02% ... and Haas Company) as a preservative. ...
A collection of 42 spots with normal tissues from different organs of C57 mice, rat and human....
... Microarray Gene Frame® has been specifically ... frames feature the same dual strength ... Frame® range for easy removal after ... and there are three sizes available. ...
... strength adhesive system which facilitates the easy removal ... either side of the frame are of differing ... has an easy release adhesive whereas the reverse, ... bond. This means that when the coverslip is ...
Biology Products: